Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wound Care Innovations, a subsidiary of Wound Management Technologies, has entered into an agreement with Quad Xenos Partners, a service disabled veteran owned small business, to market and distribute its advanced wound care collagen product, CellerateRx, to federal government agencies in the US.
Subscribe to our email newsletter
According to Wound Management Technologies, CellerateRx is FDA cleared as a medical device and is indicated for all acute and chronic wounds except for third degree burns.
Cathy Bradshaw, president of Wound Care Innovations, said: “We are excited about the opportunities presented by this relationship. It will enable us to facilitate government sales in the many inpatient and outpatient VA centers around the country as well as the other government agencies.”